All entries for: BioAtla

May 6, 2025

BioAtla

Neutral Outlook

San Diego, CA
51-200 employees

Thus, while it is unclear how certain provisions of the IRA will be implemented, the IRA will likely have a significant impact on the pharmaceutical industry. It is unclear to what extent other statutory, regulatory, and administrative initiatives will be enacted and implemented, and to what extent these or any future legislation or regulations by the current administration or subsequent administrations will have on our business, including market acceptance, and sales, of our products and product candidates.

Disease Area: Oncology
Drug Type: Biologic
March 28, 2025

BioAtla

Layoffs

San Diego, CA
51-200 employees

Looking to cut back on costs and streamline its structure, BioAtla is reducing its headcount by approximately 30%, according to an SEC filing on Thursday.

Disease Area: Oncology
Drug Type: Biologic
Scroll to Top